Improved HPLC method for doxorubicin quantification in rat plasma to study the pharmacokinetics of micelle‐encapsulated and liposome‐encapsulated doxorubicin formulations

An improved simple, rapid and accurate HPLC method for quantification of doxorubicin derived from micelle‐encapsulated or liposome‐encapsulated doxorubicin formulation in rat plasma was described. The mobile phase consisting of a mixture of methanol–water [containing 0.1% formic acid anhydrous and 0.1% ammonia solution (25%), pH 3.0], 60:40, was delivered at a flow rate of 1.0 mL/min. Sample preparation for micelle‐ or liposome‐encapsulated doxorubicin in rat plasma were achieved directly by protein precipitation with acetonitrile. Doxorubicin and daunorubicin (internal standard, IS) were separated on a C 18 reversed‐phase HPLC column and quantified by a fluoresence detection with an excitation wavelength of 475 nm and an emission wavelength of 580 nm. The linearity was obtained over the range of 5.0–1000.0 ng/mL and 1.0–200.0 µg/mL for doxorubicin and the lower limit of quantitation was 5.0 ng/mL. For each level of quality control samples, inter‐ and intra‐assay precision was less than 9.6 and 5.1% (relative standard deviation), respectively, and percentage error was within ±2.6%. The extraction recoveries of doxorubicin in the range of 10 ng/mL to 100 µg/mL in rat plasma were between 94.1 and 105.6%. This method was successfully applied to the pharmacokinetic study of doxorubicin formulations after i.v. administration to rats. Copyright © 2008 John Wiley & Sons, Ltd.